CN Patent

CN120265642A — 化合物及其制备方法和应用

Assigned to Junwei Beijing Biotechnology Co ltd · Expires 2025-07-04 · 1y expired

What this patent protects

提供了崁醇修饰肽化合物、制备方法、药物组合物及其用途，该化合物由崁醇与多肽通过化学偶联制备得到。该化合物可以溶解血栓，具有脑缺血保护的用途。

USPTO Abstract

提供了崁醇修饰肽化合物、制备方法、药物组合物及其用途，该化合物由崁醇与多肽通过化学偶联制备得到。该化合物可以溶解血栓，具有脑缺血保护的用途。

Drugs covered by this patent

motixafortide-acetate (MOTIXAFORTIDE ACETATE)

Patent Metadata

Patent number: CN120265642A
Jurisdiction: CN
Classification: —
Expires: 2025-07-04
Drug substance claim: No
Drug product claim: No
Assignee: Junwei Beijing Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.